Shared on27 Aug 25Fair value Increased 1.31%
Despite continued earnings disappointments, muted sales outlook, and renewed structural concerns in spirits demand, analysts see valuation support and international growth potential as mitigating factors, resulting in a marginally higher consensus Analyst Price Target for Brown-Forman, increasing from $31.44 to $31.92. Analyst Commentary Recent guidance and earnings have consistently disappointed, with Q4 results and FY26 outlook missing Street expectations, driving a continuous cycle of estimate downgrades and share de-rating.
Shared on30 Apr 25Fair value Decreased 2.38%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on23 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on16 Apr 25Fair value Decreased 0.39%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25Fair value Decreased 0.42%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Decreased 0.15%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25Fair value Decreased 1.55%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on10 Mar 25Fair value Decreased 0.41%
AnalystConsensusTarget has decreased revenue growth from 4.3% to 3.5%.